COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,755 Articles (22,502 medRxiv, 8,253 bioRxiv)

Most recent first Previous |  Page 1438: Articles 14371-14380  | Next

COVID-19 Mortality is Associated with Impaired Innate Immunity in Pre-existing Health Conditions
Lee, M. E., Chang, Y., Ahmadinejad, N., Johnson-Agbakwu, C. E., Bailey, C., Liu, L.
10.1101/2021.05.31.446476 — Posted: 2021-05-31
Antigenic minimalism of SARS-CoV-2 is linked to surges in COVID-19 community transmission and vaccine breakthrough infections
Venkatakrishnan, A., Anand, P., Lenehan, P., Ghosh, P., Suratekar, R., Siroha, A., Chowdhury, D. R., OHoro, J. C., Yao, J. D., Pritt, B. S., Norgan, A., Hurt, R. T., Badley, A. D., Halamka, J. D., Soundararajan, V.
10.1101/2021.05.23.21257668 — Posted: 2021-05-31 Discussion: Onsite
Favorable outcome on viral load and culture viability using Ivermectin in early treatment of non-hospitalized patients with mild COVID-19, A double-blind, randomized placebo-controlled trial.
Biber, A., Mandelboim, M., Harmelin, G., Lev, D., Ram, L., Shaham, A., Nemet, I., Kliker, L., Erster, O., Schwartz, E.
10.1101/2021.05.31.21258081 — Posted: 2021-05-31 Discussion: Onsite | Offsite
Kite-shaped molecules block SARS-CoV-2 cell entry at a post-attachment step
Chan, S.-W., Shafi, T., Ford, R.
10.1101/2021.05.29.446272 — Posted: 2021-05-31
Complete protection by a single dose skin patch delivered SARS-CoV-2 spike vaccine
McMillan, C. L. D., Choo, J. J. Y., Idris, A., Supramaniam, A., Modhiran, N., Amarilla, A. A., Isaacs, A., Cheung, S. T. M., Liang, B., Bielefeldt-Ohmann, H., Azuar, A., Acharya, D., Kelly, G., Fernando, G. J. P., Landsberg, M. J., Khromykh, A. A., Watterson, D., Young, P. R., McMillan, N. A. J., Muller, D. A.
10.1101/2021.05.30.446357 — Posted: 2021-05-31
Functional characterization of SARS-CoV-2 vaccine elicited antibodies in immunologically naive and pre-immune humans
Forgacs, D., Jang, H., Abreu, R. B., Hanley, H. B., Gattiker, J. L., Jefferson, A. M., Ross, T. M.
10.1101/2021.05.29.445137 — Posted: 2021-05-31
SARS-CoV-2-specific memory B cells can persist in the elderly despite loss of neutralising antibodies
Jeffery-Smith, A., Burton, A. R., Lens, S., Rees-Spear, C., Patel, M., Gopal, R., Muir, L., Aiano, F., Doores, K. J., Chow, J. Y., Ladhani, S. N., Zambon, M., McCoy, L. E., Maini, M. K.
10.1101/2021.05.30.446322 — Posted: 2021-05-31
Mendelian randomization analyses show that higher acetyl-carnitine and carnitine levels in blood protect against severe Covid19
Kazmi, N., Davey Smith, G., Lewis, S. J.
10.1101/2021.05.31.21257910 — Posted: 2021-05-31
Temporal stability and detection sensitivity of the dry swab-based diagnosis of SARS-CoV-2
CG, G., Kiran, U., Kuncha, S. K., Mishra, R. K.
10.1101/2021.05.28.21258007 — Posted: 2021-05-31
The UGT2A1/UGT2A2 locus is associated with COVID-19-related anosmia
Shelton, J. F., Shastri, A. J., The 23andMe COVID-19 Team, , Aslibekyan, S., Auton, A.
10.1101/2021.05.28.21257993 — Posted: 2021-05-31 Discussion: Onsite

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).